Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9799 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9732 |
High Similarity |
NPD1934 |
Approved |
0.9281 |
High Similarity |
NPD2801 |
Approved |
0.9241 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9241 |
High Similarity |
NPD6166 |
Phase 2 |
0.9241 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.9161 |
High Similarity |
NPD3882 |
Suspended |
0.9085 |
High Similarity |
NPD4380 |
Phase 2 |
0.9067 |
High Similarity |
NPD1511 |
Approved |
0.9012 |
High Similarity |
NPD7074 |
Phase 3 |
0.9006 |
High Similarity |
NPD3818 |
Discontinued |
0.8987 |
High Similarity |
NPD5494 |
Approved |
0.8981 |
High Similarity |
NPD7075 |
Discontinued |
0.8951 |
High Similarity |
NPD7054 |
Approved |
0.8947 |
High Similarity |
NPD1512 |
Approved |
0.8917 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.891 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8896 |
High Similarity |
NPD7472 |
Approved |
0.8882 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8859 |
High Similarity |
NPD1549 |
Phase 2 |
0.8854 |
High Similarity |
NPD3817 |
Phase 2 |
0.8792 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8792 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8742 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8727 |
High Similarity |
NPD6797 |
Phase 2 |
0.8675 |
High Similarity |
NPD7251 |
Discontinued |
0.8671 |
High Similarity |
NPD7819 |
Suspended |
0.8623 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8623 |
High Similarity |
NPD7808 |
Phase 3 |
0.8616 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8608 |
High Similarity |
NPD6801 |
Discontinued |
0.8606 |
High Similarity |
NPD5844 |
Phase 1 |
0.86 |
High Similarity |
NPD2796 |
Approved |
0.8544 |
High Similarity |
NPD7411 |
Suspended |
0.8533 |
High Similarity |
NPD1510 |
Phase 2 |
0.8528 |
High Similarity |
NPD6232 |
Discontinued |
0.8516 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8466 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8452 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8393 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8323 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8267 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8267 |
Intermediate Similarity |
NPD943 |
Approved |
0.825 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8232 |
Intermediate Similarity |
NPD919 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8121 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8077 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8063 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8054 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7974 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7962 |
Intermediate Similarity |
NPD2800 |
Approved |
0.795 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7937 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7937 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7937 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7912 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7911 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.791 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7844 |
Intermediate Similarity |
NPD3749 |
Approved |
0.784 |
Intermediate Similarity |
NPD920 |
Approved |
0.7798 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1933 |
Approved |
0.774 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7722 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7707 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7706 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7702 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7688 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.767 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7662 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7658 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7658 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7654 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.764 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7627 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7627 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7605 |
Intermediate Similarity |
NPD37 |
Approved |
0.7595 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7574 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7558 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7554 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7541 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7541 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7514 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7474 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7457 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7457 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7451 |
Intermediate Similarity |
NPD1203 |
Approved |
0.744 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7433 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7425 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7419 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7414 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7412 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7316 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7296 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7284 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7263 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7257 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7255 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7251 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7235 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7233 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7225 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7225 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7207 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7195 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7186 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7127 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7127
|
Intermediate Similarity |
NPD7038 |
Approved |